Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease
- PMID: 1295627
- DOI: 10.2169/internalmedicine.31.1298
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease
Abstract
After 9 years of treatment for Parkinson's disease, a 68-year-old woman developed the complications of neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) while she was still receiving levodopa, bromocriptine and amantadine hydrochloride. The patient displayed a high fever (40 degrees C), impaired consciousness, marked systemic muscle rigidity, tremor and bloody stools. The diagnosis of NMS and DIC was made on the basis of the symptoms and the results of blood serological tests. The antiparkinsonian drugs that had been administered until her admission to our hospital were continued unchanged, while the NMS was treated with dantrolene sodium and the DIC, with nafamostat mesilate. Both of the above-mentioned therapies were effective. The present case is rare in that the patient developed NMS and DIC during treatment and not after the discontinuation of the antiparkinsonian drugs.
Similar articles
-
[Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].Rinsho Shinkeigaku. 1991 Jan;31(1):62-7. Rinsho Shinkeigaku. 1991. PMID: 2044308 Review. Japanese.
-
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].Rinsho Shinkeigaku. 1999 Jun;39(6):653-7. Rinsho Shinkeigaku. 1999. PMID: 10502992 Japanese.
-
[Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].Nihon Ronen Igakkai Zasshi. 1998 Feb;35(2):139-44. doi: 10.3143/geriatrics.35.139. Nihon Ronen Igakkai Zasshi. 1998. PMID: 9584493 Japanese.
-
[Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].Masui. 2013 Dec;62(12):1453-6. Masui. 2013. PMID: 24498782 Japanese.
-
Malignant syndrome in Parkinson's disease: concept and review of the literature.Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S3-9. doi: 10.1016/s1353-8020(02)00125-6. Parkinsonism Relat Disord. 2003. PMID: 12735909 Review.
Cited by
-
Serotonin syndrome caused by escitalopram in Parkinson's disease psychosis: a case report.BMC Geriatr. 2024 Sep 18;24(1):769. doi: 10.1186/s12877-024-05371-w. BMC Geriatr. 2024. PMID: 39294572 Free PMC article.
-
Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases.Medicine (Baltimore). 2015 Jul;94(28):e1118. doi: 10.1097/MD.0000000000001118. Medicine (Baltimore). 2015. PMID: 26181547 Free PMC article.
-
Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and Mortality.Psychosom Med. 2018 May;80(4):370-376. doi: 10.1097/PSY.0000000000000574. Psychosom Med. 2018. PMID: 29521882 Free PMC article.
-
Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: Two Cases and Literature Review.J Parkinsons Dis. 2022;12(6):1727-1735. doi: 10.3233/JPD-223362. J Parkinsons Dis. 2022. PMID: 35811538 Free PMC article. Review.
-
Dysregulated Coagulation in Parkinson's Disease.Cells. 2024 Nov 13;13(22):1874. doi: 10.3390/cells13221874. Cells. 2024. PMID: 39594622 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical